Norbert Lill

Title: Norbert Lill: Innovator in Pharmaceutical Formulations

Introduction

Norbert Lill is a notable inventor based in Kronberg, Germany. He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of insulin preparations. With a total of 2 patents, Lill's work has the potential to impact the treatment of diabetes and related conditions.

Latest Patents

Lill's latest patents focus on acidic insulin preparations that exhibit improved stability. The first patent describes a pharmaceutical formulation that includes a polypeptide selected from insulin, its metabolites, analogs, derivatives, and combinations thereof. This formulation also incorporates surfactants, preservatives, and optional isotonicizing agents, all while maintaining a pH in the acidic range. The second patent mirrors the first, emphasizing the same innovative approach to enhancing the stability of insulin preparations.

Career Highlights

Norbert Lill is currently associated with Sanofi-Aventis Deutschland GmbH, a leading company in the pharmaceutical industry. His work at Sanofi has allowed him to focus on developing advanced formulations that can improve patient outcomes. Lill's expertise in this area has positioned him as a valuable asset to his team and the broader field of pharmaceutical research.

Collaborations

Lill collaborates with Anette Brunner-Schwarz, a fellow researcher who shares his commitment to advancing pharmaceutical science. Their partnership exemplifies the collaborative spirit that drives innovation in the industry.

Conclusion

Norbert Lill's contributions to pharmaceutical formulations, particularly in the realm of insulin preparations, highlight his role as an influential inventor. His patents reflect a dedication to improving the stability and efficacy of essential medications. Through his work at Sanofi-Aventis Deutschland GmbH, Lill continues to make strides in the field, ultimately benefiting patients worldwide.